PHK
CRL icon

Point72 Hong Kong’s Charles River Laboratories CRL Stock Holding History

Point72 Hong Kong’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,377
Closed -$3.5M – 2000
2022
Q2 		$3.5M Buy
16,377
+14,089
+616% +$3.44M 0.13% 203
2022
Q1 		$650K Buy
2,288
+1,521
+198% +$469K 0.02% 638
2021
Q4 		$289K Buy
767
+516
+206% +$200K 0.01% 912
2021
Q3 		$104K Buy
+251
New +$104K ﹤0.01% 1332
2020
Q3 		– Sell
-5,735
Closed -$1M – 1244
2020
Q2 		$1M Buy
+5,735
New +$915K 0.11% 215
2020
Q1 		– Sell
-1,946
Closed -$297K – 1026
2019
Q4 		$297K Buy
+1,946
New +$269K 0.07% 233
2019
Q3 		– Sell
-934
Closed -$133K – 1057
2019
Q2 		$133K Buy
+934
New +$127K 0.04% 423
2017
Q3 		– Sell
-141
Closed -$14K – 844
2017
Q2 		$14K Sell
141
-227
-62% -$20.9K 0.01% 419
2017
Q1 		$33K Sell
368
-5,634
-94% -$479K 0.04% 316
2016
Q4 		$457K Buy
+6,002
New +$456K 0.46% 49
2016
Q1 		– Sell
-86
Closed -$7K – 533
2015
Q4 		$7K Buy
+86
New +$6.2K 0.02% 311
2015
Q3 		– Sell
-1,388
Closed -$98K – 133
2015
Q2 		$98K Sell
1,388
-600
-30% -$44.4K 0.19% 93
2015
Q1 		$158K Buy
1,988
+1,126
+131% +$83.1K 0.14% 112
2014
Q4 		$55K Buy
862
+737
+590% +$46.2K 0.05% 385
2014
Q3 		$7K Buy
+125
New +$7.15K ﹤0.01% 317

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Point72 Hong Kong's CRL Position: Q3 2022 in Review

Point72 Hong Kong sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 16,377 shares — an estimated $3.5M sold.

Point72 Hong Kong first reported a position in CRL in Q3 2014 and held it in 15 quarters. The position peaked at $3.5M in Q2 2022. 582 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Point72 Hong Kong reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 16,377 Charles River Laboratories shares in Q3 2022, an estimated $3.5M.
  • Point72 Hong Kong first reported a position in Charles River Laboratories in Q3 2014 and held it in 15 quarters.
  • Point72 Hong Kong's Charles River Laboratories position peaked at $3.5M in Q2 2022.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.